ACR Convergence 2026

November 6-11, 2026. Orlando, Florida.

View by Number View by Title View Sessions

All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z

Abstract Number: 1351

Nail Psoriasis as a Marker of Cardiometabolic Risk in Psoriatic Arthritis
Abstract Number: 1517

Nailfold Capillaroscopy For Disease Activity Assessment in Juvenile Dermatomyositis
Abstract Number: 0580

Nailfold Capillary Abnormalities in Juvenile Systemic Sclerosis Compared with Juvenile Localized Scleroderma as a Disease Control
Abstract Number: 2530

National Burden, Outcomes, and Resource Utilization Associated With Antiphospholipid Syndrome and Thrombotic Microangiopathy Phenotypes During Cancer Hospitalizations: A National Inpatient Sample Analysis, 2018-2022
Abstract Number: 1627

National Prevalence and Demographic Distribution of Granulomatous Mastitis: An Epic Cosmos Analysis
Abstract Number: 2924

National Trends in Rheumatoid Arthritis Hospitalizations, All-Cause Readmissions and Resource Utilization in the United States: A Nationwide Readmissions Database Study, 2010-2021
Abstract Number: 2138

Nationwide Analysis of Factors Associated with In-Hospital Mortality in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Abstract Number: 0433

Natural history of diffuse cystic lung disease in patients with Sjogren’s disease
Abstract Number: 0688

Nebulized Pirfenidone (AP01) for Progressive Pulmonary Fibrosis in Connective Tissue Disease-associated and Other Interstitial Lung Diseases: 4-year Data from the ATLAS Open Label Extension Trial
Abstract Number: 0180

Necrotizing Vasculitis in Connective Tissue Diseases: A Multicenter Retrospective Study of 16 Patients
Abstract Number: 2787

Need for Novel Care Delivery Models in Mitigation of Cardiovascular Disease Risk for Rheumatoid Arthritis and Psoriatic Arthritis Patients
Abstract Number: 0773

Neighborhood Deprivation and Financial Burden Among Children and Young Adults With Rheumatic Disease
Abstract Number: 2139

Neighborhood Deprivation as a Risk Factor for Progression to End-Stage Kidney Disease in ANCA-Associated Vasculitis: Experiences from a Large Rural Tertiary Care Rheumatology Referral Center
Abstract Number: 1904

Neoantigens Recognized by B and T Cells are Generated by Aberrant mRNA Splicing in Lupus Neutrophils
Abstract Number: 1056

Neoself IgG Breaks Self-Tolerance in Rheumatoid Arthritis
Abstract Number: 2914

Nerandomilast in Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease: Subgroup Analysis of the Phase III FIBRONEER™-ILD Trial
Abstract Number: 0972

Nerandomilast, a Preferential Phosphodiesterase 4B Inhibitor, Dampens T-Cell Activation and Effector Function
Abstract Number: 1033

Network-based Integration of Multi-omics Data Identifies Novel Differential Molecules Differentiating Psoriatic Arthritis and Cutaneous Psoriasis
Abstract Number: 1022

Neurobehavioral Outcomes and Immune Cell Population Dynamics Influence Cognitive Deficits in SLE
Abstract Number: 0181

Neurological involvement and elevated erythrocyte sedimentation rate may predict relapse in the Takayasu Arteritis Early Inception Cohort
Abstract Number: 1387

Neurological manifestations in primary Sjögren’s syndrome
Abstract Number: 2828

Neurotrophin signaling in synovial fibroblasts sustains pathological vascular maturation in rheumatoid arthritis
Abstract Number: 2819

Neurovascular Remodeling and Dorsal Root Ganglion Spatial Transcriptomic Alterations in a Murine ACLT Model of Osteoarthritis
Abstract Number: 0048

Neutrophil Gasdermin D Pores Link Innate Immunity and Immunothrombosis in Antiphospholipid Syndrome
Abstract Number: 1993

Neutrophil NETosis mediates kidney inflammation in UVB-irradiated lupus-prone mice
Abstract Number: 0049

Neutrophil-Derived Migrasomes as New Mediators of Thromboinflammation in Antiphospholipid Syndrome
Abstract Number: 2176

Neutrophil-to-Lymphocyte Ratio Is Associated With Progression From VEDOSS to Definite Systemic Sclerosis
Abstract Number: 0661

New onset heart failure is associated with MI and VTE in immune mediated necrotizing myositis
Abstract Number: 0744

New-Onset Autoimmune Toxicities following Chimeric Antigen Receptor T-Cell Therapy: A Real-World Analysis
Abstract Number: 2262

New-onset gastrointestinal involvement in systemic sclerosis: incidence across disease-duration windows, clinical predictors and prognostic implications from the EUSTAR cohort
Abstract Number: 0367

New-onset Non-infectious Uveitis in Patients with Axial Spondyloarthritis Treated With Upadacitinib and Monoclonal TNF Inhibitors
Abstract Number: 0961

NFKB1 gene expression as a reliable diagnostic biomarker for IgA vascuilitis
Abstract Number: 1968

Nicotinamide Deficiency Impairs NAD⁺ Synthesis and Drives Fibrosis
Abstract Number: 0774

Nine-Year GP-Specialist Collaboration in Rheumatology: A 50% Reduction in Specialist Follow-Up Visits Creates Capacity for 362 Additional New Patient Consultations
Abstract Number: 0221

Nintedanib in Progressive Systemic Sclerosis-Associated Interstitial Lung Disease on Background Immunosuppression: Real-World Outcomes, Treatment Escalation, and Risk Stratification
Abstract Number: 2939

Nipocalimab For Warm Autoimmune Hemolytic Anemia: Results From a Phase 2/3 Randomized Double-blind Study
Abstract Number: 0875

Nipocalimab in SLE: First-in-Class Efficacy and Safety Results Demonstrating Proof of Concept For FcRn Blockade From a Phase 2 study
Abstract Number: 0973

NKB61: A Novel PD-1 Agonist/CD16A Bispecific Antibody with Selective Depletion of Pathogenic PD-1+ T Cells and Favorable Safety Profile for Autoimmune Disease Therapy
Abstract Number: 1927

NLRP3 inhibition as a potential therapeutic approach for inflammatory knee osteoarthritis: results from a Phase II study
Abstract Number: 2848

NOD2 Variants in a Pediatric Population: Genotype-Phenotype Patterns and a Comparison to Adult Yao Syndrome
Abstract Number: 0085

Non-coding RNA biomarkers distinguish between difficult-to-treat rheumatoid arthritis and stable remission
Abstract Number: 2177

Non-Invasive Measurement of Baseline Skin Stiffness Modulus as Measured by a Wearable Skin Sensor Compared to the Modified Rodnan Skin Score
Abstract Number: 0322

Non-invasive Surveillance of the Presence of Lupus Nephritis and its Response to Therapy using the RAIL Urine Biomarkers in the GLADEL Cohort
Abstract Number: 1023

Non-lesional Lupus Keratinocytes Exhibit Inflammatory and Chemotactic Skewing Following Ultraviolet Light Exposure
Abstract Number: 1007

Non-Responder Status and Biopsy Chronicity in Lupus Nephritis Associate with Markers of Senescence and Hypoxia Across Kidney Cell Types
Abstract Number: 1008

Nonresponse to hydroxychloroquine in cutaneous lupus is associated with increased type I interferon signatures in epidermal and stromal cells.
Abstract Number: 2902

North American Expert Consensus on Atherosclerotic Cardiovascular Disease Risk Screening and Management in Adults with Lupus Nephritis
Abstract Number: 2596

Not All Myositis-ILD Is Equal: Subtype-Specific Inpatient Outcomes in Inflammatory Myopathy-Associated Interstitial Lung Disease – A Nationally Representative Cohort
Abstract Number: 0882

Not All Sacroiliitis Is the Same: A Distinct Structural MRI Phenotype in Enteropathic Spondyloarthritis
Abstract Number: 0119

Novel autoantibodies against membrane repair machinery in juvenile dermatomyositis
Abstract Number: 0035

Novel cytokine candidate, p40-EBI3 complex regulates profibrotic T cell and B cell and inhibits systemic sclerosis via simultaneous regulation of STAT3/STAT5 signals
Abstract Number: 0135

Novel Signal Transducer and Activator of Transcription 3 (STAT3) Mutation Mimicking Systemic Juvenile Idiopathic Arthritis (sJIA) is Linked to Unique Immune Cell Characteristics
Abstract Number: 1275

Novel T Cell Biomarkers Demonstrate High Specificity for SLE and a Significant Positive Relationship with the MAP (AVISE Lupus) Index
Abstract Number: 0392

Number Needed to Screen for Axial Spondyloarthritis: Preliminary Results from the FASTRAX Cohort

All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z